La vaccination contre la varicelle

Flahaut, 1995, Epidémiologie des maladies transmissibles en médecine générale : bilan du réseau sentinelle 1994, Bull Epidemiol Hebd, 20, 87 2004, Avis du Conseil Supérieur d’Hygiène Publique de France (section des maladies transmissibles) relatif à la vaccination contre la varicelle : séance du 19 mars 2004, Bull Epidemiol Hebd, 28-29, 127 Levrat, 2003, Caractéristiques cliniques des varicelles hospitalisées en réanimation pédiatrique de 1998 à 2001 en France : le groupe francophone d’urgence et de réanimation pédiatriques, Bull Epidemiol Hebd, 9, 51 U.S. Department of Health and Human Services, 1996, Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices, MMWR Morb Mortal Wkly Rep, 45, 1 U.S. Department of Health and Human Services, 1999, Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices, MMWR Morb Mortal Wkly Rep, 48, 1 Chan, 2002, Use of statistical models for evaluating antibody response as a correlate of protection against varicella, Stat Med, 2, 3411, 10.1002/sim.1268 Weibel, 1984, Live attenuated varicella virus vaccine: efficacy trial in healthy children, N Engl J Med, 310, 1409, 10.1056/NEJM198405313102201 Krause, 1995, Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine, J Pediatr, 127, 518, 10.1016/S0022-3476(95)70106-0 Gershon, 1988, Immunization of healthy adults with live attenuated varicella vaccine, J Infect Dis, 158, 132, 10.1093/infdis/158.1.132 Arvin, 1992, Cell-mediated immunity to varicella-zoster virus, J Infect Dis, 166, S35, 10.1093/infdis/166.Supplement_1.S35 Meurice, 1996, Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children, J Infect Dis, 174, S324, 10.1093/infdis/174.Supplement_3.S324 Ramkissoon, 1995, Immunogenicity and safety of a live attenuated varicella vaccine in healthy children aged 9–24 months, S Afr Med J, 85, 1295 Ampofo, 2002, Persistence of immunity to live attenuated varicella vaccine in healthy adults, Clin Infect Dis, 34, 774, 10.1086/338959 Kuter, 1991, Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study 7-year follow-up studies, Vaccine, 9, 643, 10.1016/0264-410X(91)90189-D Ross, 1962, Modification of chicken pox in family contacts by administration of gamma globulin, N Engl J Med, 267, 369, 10.1056/NEJM196208232670801 Varis, 1996, Efficacy of high-titer live attenuated varicella vaccine in healthy young children, J Infect Dis, 174, S330, 10.1093/infdis/174.Supplement_3.S330 Salzman, 1998, Postexposure varicella vaccination in siblings of children with active varicella, Pediatr Infect Dis J, 17, 256, 10.1097/00006454-199803000-00020 Watson, 2000, Postexposure effectiveness of varicella vaccine, Pediatrics, 105, 84, 10.1542/peds.105.1.84 Arbeter, 1986, Varicella vaccine studies in healthy children and adults, Pediatrics, 78, 748 Seward, 2002, Varicella disease after introduction of varicella vaccine in the United States, 1995-2000, JAMA, 287, 606, 10.1001/jama.287.5.606 Galil, 2002, Hospitalization for varicella in the United States, 1988 to 1999, Pediatr Infect Dis J, 21, 931, 10.1097/00006454-200210000-00009 Nguyen, 2005, Decline in mortality due to varicella after implementation of varicella vaccination in the United States, N Engl J Med, 352, 450, 10.1056/NEJMoa042271 Clements, 1999, Postlicensure study of varicella vaccine effectiveness in a day-care setting, Pediatr Infect Dis J, 18, 1047, 10.1097/00006454-199912000-00004 Vazquez, 2001, The effectiveness of the varicella vaccine in clinical practice, N Engl J Med, 344, 955, 10.1056/NEJM200103293441302 Gershon, 1990, Live attenuated varicella vaccine: protection in healthy adults in comparison to leukemic children: NIAID-Collaborative-Varicella-Vaccine-Study-Group, J Infect Dis, 161, 661, 10.1093/infdis/161.4.661 Shields, 2001, Varicella vaccine exposure during pregnancy: data from the first 5years of the pregnancy registry, Obstet Gynecol, 98, 14 Haas, 1985, Active immunization against varicella of children with acute leukemia or other malignancies on maintenance chemotherapy, Postgrad Med J, 61, 69 Heath, 1987, Experience with the live Oka-strain vaccine in children with solid tumors, Arch Dis Child, 62, 569, 10.1136/adc.62.6.569 Zamora, 1994, Attenuated varicella virus vaccine in children with renal transplants, Pediatr Nephrol, 8, 190, 10.1007/BF00865476 Gagnadoux, 1998, Prévention de la varicelle chez les transplantés rénaux, J Pediatr Puericulture, 11, 226 Donati, 2000, Response to varicella immunization in pediatric liver transplants recipients, Transplantation, 70, 1401, 10.1097/00007890-200011150-00023 Sauerbrei, 1997, Varicella vaccination in children after bone marrow transplantation, Bone Marrow Transplant, 20, 381, 10.1038/sj.bmt.1700909 Alpay, 2002, Varicella vaccination in children with steroid-sensitive nephrotic syndrome, Pediatr Nephrol, 17, 181, 10.1007/s00467-001-0789-7 Asano, 1996, Varicella vaccine: the Japanese experience, J Infect Dis, 174, S310, 10.1093/infdis/174.Supplement_3.S310 Ozaki, 2000, Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects: 10-year survey at pediatric clinic, Vaccine, 18, 2375, 10.1016/S0264-410X(00)00016-5 Takayama, 1997, High incidence of breakthrough varicelle observed in healthy children immunized with live attenuated varicella vaccine (Oka strain), Acta Paediatr Jpn, 39, 663, 10.1111/j.1442-200X.1997.tb03664.x Izurieta, 1997, Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center, JAMA, 278, 1495, 10.1001/jama.1997.03550180045035 Buchholz, 1999, Varicella outbreaks after vaccine licensure: should they make you chicken?, Pediatrics, 104, 561, 10.1542/peds.104.3.561 Vazquez, 2004, Effectiveness over time of varicella vaccine, JAMA, 291, 851, 10.1001/jama.291.7.851 Galil, 2002, Outbreak of varicella at a day-care center despite vaccination, N Engl J Med, 347, 1909, 10.1056/NEJMoa021662 Gerhson, 2002, Varicella vaccine: are two doses better than one?, N Engl J Med, 347, 1962, 10.1056/NEJMe020138 Kuter, 2004, Ten year follow-up of healthy children who received one or two injections of varicella vaccine, Pediatr Infect Dis J, 23, 132, 10.1097/01.inf.0000109287.97518.67 Black, 1999, Postmarketing evaluation of the safety and effectiveness of varicella vaccine, Pediatr Infect Dis J, 18, 1041, 10.1097/00006454-199912000-00003 Sharrar, 2001, The postmarketing safety profile of varicella vaccine, Vaccine, 19, 916, 10.1016/S0264-410X(00)00297-8 Scheifele, 2002, Three-year follow-up of protection rates in children given varicella vaccine, Can J Infect Dis, 13, 382, 10.1155/2002/907087 Krause, 2000, Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children, Nat Med, 6, 451, 10.1038/74715 Thomas, 2002, Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study, Lancet, 360, 678, 10.1016/S0140-6736(02)09837-9 Brisson, 2002, Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox, Vaccine, 20, 2500, 10.1016/S0264-410X(02)00180-9 Goldman, 2003, Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage, Vaccine, 21, 4243, 10.1016/S0264-410X(03)00459-6 Huse, 1994, Childhood vaccination against chicken pox: an analysis of benefits and costs, J Pediatr, 124, 869, 10.1016/S0022-3476(05)83173-7 Beutels, 1996, Costs and benefits of routine varicella vaccination in German children, J Infect Dis, 174, S335, 10.1093/infdis/174.Supplement_3.S335 Banz, 2003, The cost-effectiveness of routine childhood varicella vaccination in Germany, Vaccine, 21, 1256, 10.1016/S0264-410X(02)00431-0 Coudeville, 2005, The economic value of childhood varicella vaccination in France and in Germany, Value Health, 8, 209, 10.1111/j.1524-4733.2005.04005.x